CI Stock Price Today (October 2026) — The Cigna Group Analysis & Key Metrics 2026-10-20
The Cigna Group (CI) is trading at $306.60, up 2.71% today (as of October 2026). The stock continues to show sustained strength above key moving averages, attracting attention from investors looking for Healthcare growth opportunities.
- According to consensus analyst estimates, the 1-year price target is $342.29 (11.6% upside).
- Volatility is low (18.78% annualized), implying relatively contained price movements for short-term traders.
- The fundamental picture, based on the latest financial filings, is nuanced: solid revenue growth (6.70% YoY) alongside competitive pressures in the Healthcare Plans space.
CI Stock Analysis: Key Metrics & Valuation (October 2026)
Concise, actionable data for investors
The Cigna Group - Historical Price & Volume
- Price
- Volume
- Latest price
Market Cap
Enterprise Value: $105.64B
P/E Ratio
Forward P/E: 8.24
Revenue Growth
Year over Year
Analyst Target
+11.6% upside potential
Key Investor Questions About CI
What investors need to know before buying
Based on current market data, CI presents a overbought technical setup with looking solid fundamentals.
- Technicals say: Overbought (RSI 77.07)
- Fundamentals say: Looking solid (debt and growth supportive)
CI's growth trajectory depends on its ability to expand within the Healthcare Plans sector while managing margin pressures.
- Future growth will depend on performance in core Healthcare Plans operations.
- The ability to manage competitive pressures will be crucial for sustained growth.
The primary risks for CI investors include debt exposure and competitive dynamics in the Healthcare Plans industry.
- $31.88B in debt could be a headwind in a high-rate environment.
- Fierce competition from established players in Healthcare Plans.
52-Week Trading Range
Over the past year, CI stock traded between $239.51 and $311.34 and currently trades near the high end of that range. Big swings are less likely unless a major catalyst emerges.
Volatility & Risk Profile
With 18.78% annualized volatility and β=0.16, the stock exhibits low sensitivity to market moves—making CI suitable for investors comfortable with active risk management.
Institutional & Insider Ownership
High institutional ownership with low short interest suggests steadier hands and low immediate risk.
Analyst Sentiment & Price Targets
Latest News & Headlines
Recent headlines, coverage and TickZen analysis
Market news
How CVS' Aetna Is Advancing Efforts to Reduce Administrative Burden
What Are Hims & Hers Health Stock Bears Missing?
Management Raised The Bar For CVS Health Stock; Does The Chart Agree?
What Would It Take For Rising Medical Costs To Break UnitedHealth Stock?
1 Large-Cap Stock to Research Further and 2 We Avoid
Where Could UnitedHealth's Next Growth Come From?
Latest TickZen Insights
All insights →No TickZen article on CI yet. Our newest analysis:
Explore More Analysis for CI
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.
Earnings snapshot
Next report Nov 5, 2026 (before the open)
Frequently Asked Questions
Common investor questions about The Cigna Group
The Cigna Group (CI) is currently trading at $306.60. The RSI (14-day) is at 77.1, indicating overbought territory (potentially overheated). Wall Street analysts have a consensus "buy" recommendation. The mean analyst price target of $342.29 implies 11.6% upside from current levels. Volatility is low at 18.8% annualized, meaning price movements are relatively contained. Investors should consider their risk tolerance, investment horizon, and portfolio diversification before making a decision.
Based on current valuation metrics for The Cigna Group (CI): The trailing P/E ratio is 12.12, which is below the market average of ~20-22, suggesting the stock may be undervalued relative to peers. The forward P/E is 8.24, lower than the trailing P/E, suggesting analysts expect earnings improvement. The PEG ratio is 0.83, below 1.0, which generally indicates the stock is undervalued relative to its growth rate. Price-to-Book is 1.79. Price-to-Sales is 0.27. Valuation should be compared to Healthcare Plans industry peers for context, as different sectors trade at different multiples.
Based on 24 analysts covering CI, the consensus price target is $342.29. This represents a 11.6% upside from the current price of $306.60. The range spans from a low target of $288.00 to a high target of $400.00, reflecting varying levels of optimism among analysts. The consensus recommendation is "buy". Note: Analyst price targets are forward-looking estimates and not guarantees of future performance.
Yes, The Cigna Group (CI) pays a dividend with a current yield of approximately 2.21%. The annualized dividend rate is $6.14 per share. The payout ratio is 25.4%, which is conservative and suggests the dividend is well-covered by earnings with room for future increases. The most recent ex-dividend date was Sep 8, 2026.
Key risks for The Cigna Group (CI) investors include: 1. Broader market and macroeconomic risks (interest rates, inflation, geopolitical events). 2. Healthcare Plans sector-specific competitive pressures. Investors should diversify and consider their risk tolerance before investing.
Here is The Cigna Group's (CI) current debt and financial health profile: Total debt stands at $31.88B. The debt-to-equity ratio is 0.74x, which is moderate and generally manageable for most companies. The current ratio is 0.85, which is below 1.0 and may indicate short-term liquidity concerns. The quick ratio is 0.69. The company holds $7.26B in cash and equivalents. Free cash flow is positive at $7.98B, providing a cushion for debt servicing and shareholder returns.